¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"minimal nerve excitability test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® sensory nerve ÇÑ±Û °¨°¢½Å°æ
¼³¸í   
  °¨°¢¼¼Æ÷°¡ ¹ÞÀº ÀÚ±ØÀ» ÁßÃ߽Ű濡 Àü´ÞÇϴ ½Å°æ. ´«À̳ª ÇǺΠµî¿¡ Àִ °¨°¢±â°¡ ¿ÜºÎ·ÎºÎÅÍ ÀÚ±ØÀ» ¹ÞÀ¸¸é °¨°¢½Å°æÀ» °ÅÃĠô¼ö¿Í ´ë³ú°ÑÁú±îÁö °¨°¢ÀÌ Àü´ÞµÈ´Ù. À̿͠°°ÀÌ ¿ÜºÎ·ÎºÎÅÍ ³»ºÎ¸¦ ÇâÇØ Àü´ÞµÇ´Â °¨°¢½Å°æÀº ±¸½É¼º ½Å°æ°èÅëÀ̸ç, ¿ø½É¼º ¿îµ¿½Å°æ°èÅë ¹× ÀÚÀ²½Å°æ°èÅë¿¡ ÇÊÀûÇϴ ¸»ÃʽŰæÀÇ ÇϳªÀÌ´Ù. ÀÌ °¨°¢½Å°æ¿¡´Â Èİ¢½Å°æ(³ú½Å°æ¥°)-½Ã°¢½Å°æ(³ú½Å°æ¥±)-´«µ¹¸²½Å°æ(³ú½Å°æ¥²)-»ïÂ÷½Å°æ(³ú½Å°æ¥´)-¾ó±¼½Å°æ(³ú½Å°æ¥¶)-û°¢½Å°æ(³ú½Å°æ¥·)-ÇôÀενŰæ(³ú½Å°æ¥¸)-¹ÌÁֽŰæ(³ú½Å°æ¥¹) ¹× Ã´¼ö½Å°æÀÌ ÀÖ´Ù. °¨°¢½Å°æ Áß ¹ÌÁֽŰæÀ» Á¦¿ÜÇϸ頸ðµÎ µÎºÎ¿¡ ºÐÆ÷µÇ¾î ÀÖ°í, Èİ¢½Å°æ-½Ã°¢½Å°æ-û°¢½Å°æÀÇ ¼¼°¡Áö´Â Æ¯È÷ ºÐÈ­µÈ °¨°¢»óÇǸ¦ Áö¹èÇÑ´Ù. ÇôÀενŰæÀº ¹Ì°¢ÀÇ ¸»´ÜÀåÄ¡¿Í ±× ¹ÛÀÇ ºÎºÐ¿¡ ¿¬°áµÇ°í ¹ÌÁֽŰæÀº Èä°­°ú º¹°­ÀÇ ±â°ü¿¡ ºÐÆ÷µÇ¾î ±¸½É¼º Ãæ°ÝÀ» ÁßÃß¿¡ Àü´ÞÇϸ砻ïÂ÷½Å°æÀº Ã´¼öÀÇ °¢ ¸¶µð¿¡ Àִ ½Å°æ¿¡ ÇØ´çÇÏ¿©(¸Ó¸®ÀÇ ÇǺÎ-Á¡¸· µîÀǠǥ¸é°¨°¢°ú ½ÉºÎ°¨°¢À» °üÀåÇÑ´Ù. Ã´¼öÀÇ °¨°¢½Å°æ°èÅë¿¡µµ ÇǺο͠½ÉºÎ, ³»ÀåÀÇ ºÐÆ÷¿¡ µû¸¥ ±¸º°ÀÌ ÀÖ´Ù. 
¿µ¹® cranial nerve ÇÑ±Û ³ú½Å°æ
¼³¸í   
  ´ëºÎºÐÀÇ ½Å°æÀº Ã´¼ö¸¦ ÅëÇØ¼­ ³ª°£´Ù. ±×·¯³ª ¸î¸îÀÇ ½Å°æÀº ³ú¿¡¼­ ¹Ù·Î ³ª°£´Ù. ÀÌ·¸°Ô ³ú¿¡¼­ ¹Ù·Î ³ª°¡´Â ½Å°æÀ» ³ú½Å°æÀ̶ó°í ÇÑ´Ù. ÀÌ ³ú½Å°æÀº 12°³·Î ¸ðµÎ ´ëĪÀûÀΠ½ÖÀ¸·Î Á¸ÀçÇÑ´Ù. ÀÌ ³ú½Å°æÀº ÁַΠƯ¼ö°¨°¢(½Ã°¢, Ã»°¢, Èİ¢, ¹Ì°¢)°ú ¾ó±¼ µîÀÇ ÀϺΠ±ÙÀ°À» Áö¹èÇÏ°í ½ÉÀåÀ̳ª ³»ÀåÀÇ Áö¹èµµ ÀϺΠ´ã´çÇϰí ÀÖ´Ù. 12°³ÀÇ ½Å°æÀº °¢°¢ ´ÙÀ½°ú °°Àº À̸§°ú °íÀ¯¹øÈ£¸¦ °¡Áö°í ÀÖ´Ù.
  
  -Èİ¢½Å°æ(olfactory nerve)£­Èİ¢À» ´ã´çÇϴ ½Å°æ,
  
  -½Ã°¢½Å°æ(optic nerve)£­½Ã°¢À» ´ã´çÇϴ ½Å°æ.
  
  -´«µ¹¸²½Å°æ(oculomotor nerve)£­¿îµ¿À» ´ã´çÇϴ ½Å°æ,
  
  -µµ¸£·¡½Å°æ(trochlear nerve)£­´«ÀÇ ¿îµ¿À» ´ã´çÇϴ ½Å°æ.
  
  -»ïÂ÷½Å°æ(trigeminal nerve)£­3°³ÀÇ °¡Áö¸¦ °¡Áö´Â ½Å°æÀ¸·Î ¾ó±¼ÀÇ °¨°¢°ú ¾Ã±â¸¦ À§ÇÑ ±ÙÀ°À» ¿òÁ÷À̴ ¿ªÇÒÀ» ÇÑ´Ù.
  
  -°¡µ¹¸²½Å°æ(abducent nerve)£­´«ÀÇ ¿îµ¿À» ´ã´çÇϴ ½Å°æ.
  
  -¾ó±¼½Å°æ(facial nerve)£­¾ó±¼ ±ÙÀ°ÀÇ ¿îµ¿À» ´ã´çÇϴ ½Å°æ. Áï ¾ó±¼ÀÌ ¿©·¯ °¡Áö Ç¥Á¤À» ³»´Â °ÍÀº ÀÌ ½Å°æÀÇ ÀÛ¿ëÀÌ´Ù. ±×¸®°í ÇôÀÇ ¾ÕºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇϴ ¿ªÇÒµµ ÇÑ´Ù.
  
  -¾È¶ã´ÞÆØÀ̽Űæ(vestibulocochlear nerve)£­¾È¶ã½Å°æ°ú ´ÞÆØÀ̽ŰæÀÇ 2°¡Áö ½Å°æÀ¸·Î ÀÌ·ç¾îÁø ½Å°æÀ¸·Î ¸ðµÎ ±Í¸¦ Áö¹èÇϴ ½Å°æÀÌ´Ù. ¾È¶ã½Å°æÀº ÆòÇü°¨°¢À» ´ã´çÇϴ °÷ÀΠ±ÍÀÇ ¾È¶ã¿¡¼­ ³ª¿À´Â ½Å°æÀ¸·Î ÆòÇü°¨°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ ÀüÇϴ ¿ªÇÒÀ» ÇÑ´Ù. ±×¸®°í ´ÞÆØÀ̽ŰæÀº Ã»°¢À» °¨ÁöÇϴ ´ÞÆØÀ̲®ÁúÀÇ ¸ð¾çÀ» °¡Áø ´ÞÆØÀÌ¿¡¼­ ±â¿øÇϴ ½Å°æÀ¸·Î Ã»°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ Àü´ÞÇϴ ¿ªÇÒÀ» ÇÑ´Ù.
  
  -ÇôÀενŰæ(glossopharyngeal nerve)£­¸» ±×´ë·Î Çô¿Í Àεκο¡ ºÐÆ÷Çϴ ½Å°æÀ¸·Î ÀÎÈĺÎÀÇ ¿òÁ÷ÀÓ°ú ÇôÀÇ µÞºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇÑ´Ù.
  
  -¹ÌÁֽŰæ(vagus nerve)£­¸» ±×´ë·Î ¾ÆÁÖ ¿©·¯ °÷¿¡ ºÐÆ÷ÇÏ¿© ºÐÆ÷¿µ¿ªÀÌ ¸ðÈ£ÇÑ ½Å°æÀÌ´Ù(vagus¶õ ¸ðÈ£ÇÑ À̶õ ¶æÀ» °¡Áø´Ù). ´ëºÎºÐÀÇ ³»Àå¿¡ ºÐÆ÷ÇÏ°í ¶Ç ½ÉÀå¿¡ ºÐÆ÷ÇÏ¿© ½ÉÀåÀÇ ¹Úµ¿¼ö¸¦ Á¶Á¤Çϴ ¿ªÇÒµµ ÇÑ´Ù.
  
  -´õºÎ½Å°æ(accessory nerve)£­µîÀÇ ±ÙÀ°°ú ¸ñÀÇ ±ÙÀ°ÀÇ ÀϺθ¦ Áö¹èÇϴ ½Å°æ.
  
  -Çô¹Ø½Å°æ(hypoglossal nerve)£­ÇôÀÇ ¿òÁ÷ÀÓÀ» °üÀåÇϴ ½Å°æ.
¿µ¹® afferent nerve ÇÑ±Û µé½Å°æ
¼³¸í   
  ¸öÀÇ Áß½ÉÀ¸·Î µé¾î¿À´Â ½Å°æ, Áï °¨°¢½Å°æÀ» ÁöĪÇϴ ¸»ÀÌ´Ù.
¿µ¹® peripheral nerve ÇÑ±Û ¸»ÃʽŰæ
¼³¸í   
  ÁßÃ߽Űæ°è¸¦ Á¦¿ÜÇÑ ³ª¸ÓÁö ¸ðµç½Å°æÀ» ¸»ÇÔ. ÁßÃ߽Űæ°è´Â ³ú¿Í Ã´¼ö¸¦ ¸»Çϸç, ±×¿Ü ³ª¸ÓÁö ½Å°æµé·Î½á ½ÇÁ¦ÀûÀ¸·Î °¢ ±â°üÀ̳ª »çÁö ¸»´Ü¿¡ ½Å°æÀÌ ºÐÆ÷Çϸç, ÀÚ±ØÀ» Àü´ÞÇϴ ÀÏÀ» Çϴ ½Å°æÀ» ¸ðµÎ ÅëÆ²¾î ¸»ÃʽŰæÀ̶ó ÇÑ´Ù. ³ú¿¡¼­ ¹Ù·Î ³ª¿Í ºÐÆ÷Çϴ ³ú½Å°æ°ú Ã´¼ö¿¡¼­ ±â½ÃÇϴ ô¼ö½Å°æµµ ¸ðµÎ ¸»ÃʽŰ濡 ÇØ´çÇÑ´Ù. ¶ÇÇÑ ¸»ÃʽŰ濡´Â °¢Á¾ ÀÚÀ²½Å°æÀ» ´ã´çÇϴ ±³°¨½Å°æ, ºÎ±³°¨½Å°æµµ Æ÷ÇԵȴÙ.
¿µ¹® vagus nerve ÇÑ±Û ¹ÌÁֽŰæ
¼³¸í   
  Á¦ 10³ú½Å°æ(³ú½Å°æÀº ³ú¿¡¼­ ±â½ÃÇÑ ¸»ÃʽŰæÀ¸·Î ¸ðµÎ 12°³°¡ ÀÖ´Ù)ÀÇ À̸§. ¿Ã¸®ºê¿Í ¾Æ·¡¼Ò³ú°¢(inferior cerebellopontine angle)»çÀÌ ¼û³ú ¿ÜÃø¿¡¼­ ³ª¿À´Â ¸¹Àº »Ñ¸®¼¶À¯·ÎºÎÅÍ ±â½ÃÇÏ¿© »óÈĵνŰæ, µÇµ¹ÀÌÈĵνŰæ, °æÁú¸·°¡Áö, ±Í¹ÙÄû°¡Áö, Àεΰ¡Áö, ½ÉÀå°¡Áö, ±â°üÁöÀÎÁö, À§°¡Áö, °£°¡Áö, º¹°­°¡Áö, ÄáÆÏ°¡Áö, ÀενŰæ¾ó±â(pharyngeal plexus), Æó½Å°æ¾ó±â(pulmonic plexus), ½Äµµ½Å°æ¾ó±â(esophageal plexus), Àü ¹× ÈÄ ¹ÌÁֽŰ氣(anterior & posterior vagal trunk)ÀÇ °¡Áö¸¦ ³½´Ù. ¹ÌÁֽŰæÀº ¸ñÁ¤¸Æ±¸¸Û(jugular foramen)À» ÅëÇØ ³»·Á°¡¼­ »óÇϽŰæÀý(superior & inferior ganglion)°ú ¿¬°áµÇ°í, ¸ñ ¹× °¡½¿¸¦ Áö³ª º¹ºÎ¿¡ µµ´ÞÇÑ´Ù. ±Í, Çô, ÀεÎ, Èĵο¡ °¨°¢¼ºÀ¸·Î, ÀεÎ, ÈĵΠ¹× ½Äµµ¿¡ ¿îµ¿¼ºÀ¸·Î, ±×¸®°í ÈäºÎ ¹× º¹ºÎÀÇ ±â°ü¿¡ ³»À屸½É¼ºÀ¸·Î ºÐÆ÷ÇÑ´Ù.
  
  ¹ÌÁֽŰæ
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cardiac excitability
    ½ÉÀåÈïºÐ¼º
  • excitability
    ÈïºÐ¼º
  • reflex excitability
    ¹Ý»çÈïºÐ¼º
  • minimal
    ÃÖ¼Ò-
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³óµµ
  • minimal anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö
  • minimal change disease
    ¹Ì¼¼º¯È­º´
  • minimal current gradient
    ÃÖ¼ÒÀü·ù±â¿ï±â, ÃÖ¼ÒÀü·ù°æ»ç
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal erythema dose
    ÃÖ¼ÒÈ«¹Ý¼±·®
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excitability
    ÈïºÐ¼º, ÈïºÐµµ
  • minimal invasive surgery
    ÃÖ¼Òħ½À¼ö¼ú
  • optic nerve atrophy
    (¢¡optic atrophy) ½Ã°¢½Å°æÀ§Ãà
  • intercostal nerve block
    °¥ºñ»çÀ̽ŰæÂ÷´Ü, ´Á°ñ°£½Å°æÂ÷´Ü
  • nerve compression
    ½Å°æ¾Ð¹Ú
  • afferent nerve fiber
    µé½Å°æ¼¶À¯
  • nerve fiber
    ½Å°æ¼¶À¯
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • postganglionic nerve fiber
    ½Å°æÀýÀÌÈļ¶À¯
  • preganglionic nerve fiber
    ½Å°æÀýÀÌÀü¼¶À¯
  • nerve
    ½Å°æ
  • abducens nerve
    °¡µ¹¸²½Å°æ
  • abducent nerve
    °¡µ¹¸²½Å°æ
  • accessory nerve
    ´õºÎ½Å°æ
  • afferent nerve
    µé½Å°æ, ±¸½É½Å°æ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal nerve excitability test
    ÃּҽŰæÀڱذ˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nerve excitability test
    ½Å°æÀڱذ˻ç
  • minimal stimulating test
    ¹Ì¾àÁÖÀÔÀڱؽÃÇè
  • cardiac excitability
    ½ÉÀåÈïºÐ¼º
  • local excitability disturbance
    ±¹¼ÒÈïºÐÀå¾Ö
  • excitability
    ÈïºÐ¼º, ÈïºÐµµ
  • reflex excitability
    ¹Ý»çÈïºÐ¼º
  • minimal visible angle
    Ãּҽð¢
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³»³óµµ
  • minimal anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ, ÃÖÀúÀúÁö³óµµ
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö, ¹Ì¼Ò³ú±â´ÉÀå¾Ö
  • minimal change disease
    ÃÖ¼Òº¯È­ÄáÆÏº´Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Kobraks minimal stimulation
    ÄÚºê¶ô¾àÀڱعý
  • posterior auricular nerve of facial nerve
    ¾ó±¼½Å°æÀÇ µÚ±Ó¹ÙÄû½Å°æ, ¾È¸é ½Å°æ(äÔØüãêÌè)ÀÇ ÈÄÀ̰³½Å°æ.
  • posterior auricular nerve of facial nerve
    ¾ó°óº·wÀÇ µÚõ¤aÄû½Å°æ, ¾È¸é ½Å°æ(äÔØüãêÌè)ÀÇ ÈÄÀ̰³½Å°æ. µÚ
  • G-test=£¾gonadotropin stimulation test
    °í³ªµµÆ®·ÎÇÉ ÀÚ±ØÅ×½ºÆ®. µµÆ®·ÎÇÉÁö±Ø°Ë»ç
  • Ham test=acidified serum test
    ÇÜ °Ë»ç, »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • RPR test => rapid plasma reagin test
    ½Å¼ÓÇ÷À帮¾ÆÁø<°¨ÀÛÇ×ü>½ÃÇè
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • acidified serum test=Ham test
    »ê¼ºÈ­Ç÷û°Ë»ç
  • acidified-serum lysis test=Ham test
    »ê¼ºÈ­Ç÷û¿ëÇ÷°Ë»ç
  • antiglobulin test = Coombs test
    Çױ۷κҸ°°Ë»ç
  • polyethylene glycol test =PEG test
    Æú¸®¿¡Æ¿·»±Û¸®Äݰ˻ç
  • Arnolds nerve
    ¹ÌÁֽŰæÀ̰³Áö
  • Cranial nerve
    ³ú½Å°æ(ÒàãêÌè)
  • Glossopharyngeal nerve
    ¼³ÀνŰæ(àßìÖãêÌè)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal nerve excitability test =NET
    ÃּҽŰæÀڱذ˻ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nerve excitability test [=NET]
    ½Å°æÀڱذ˻ç
  • test, nerve excitability [=NET]
    ½Å°æÀڱذ˻ç
  • cardiac excitability
    ½É(Àå)ÈïºÐ¼º(ãýíôýéÝÇàõ).
  • excitability
    ÈïºÐ¼º(ýéÝÇàõ), ÇÇÀڱؼº.
  • excitability
    ÈïºÐ¼º(ýéÝÇàõ)
  • local excitability disturbance
    ±¹¼ÒÈïºÐ¼º Àå¾Ö(¡­ýéÝÇàõî¡äô).
  • reflex excitability
    ¹Ý»çÈïºÐ¼º(¡­ýéÝÇàõ).
  • minimal stimulating test
    ¹Ì¾àÁÖÀÔÀڱعý(Ú°å°ñ¼ìýô§Ð½Ûö).
  • minimal air
    ÃÖ¼Ò°ø±â.
  • minimal angle resolution
    ÃÖ¼Ò°¢ºÐÇØ´É.
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡(õÌ á³Ê¦ôéÚÊö·).
  • minimal auditory threshold
    ÃÖ¼Ò°¡Ã»¿ªÄ¡
  • minimal bactericidal concentration (MBC)
    »ì±ÕÃÖ¼Ò³óµµ
  • minimal blood pressure
    ÃÖ¼ÒÇ÷¾Ð.
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Genu (of facial nerve)
    (¾ó±¼½Å°æ)¹«¸­
    [¿¾ ¿ë¾î] ¾È¸é½Å°æ½½
  • Transverse nerve of neck
    °¡·Î¸ñ½Å°æ
    [¿¾ ¿ë¾î] °æÈ¾½Å°æ
  • Thoracodorsal nerve
    °¡½¿µî½Å°æ
    [¿¾ ¿ë¾î] Èä¹è½Å°æ
  • Lateral pectoral nerve
    °¡Âʰ¡½¿±Ù½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÃøÈä±Ù½Å°æ
  • Lateral pterygoid nerve
    °¡Âʳ¯°³±Ù½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÃøÀ͵¹±Ù½Å°æ
  • Lateral femoral cutaneous nerve
    °¡ÂʳҴٸ®ÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃø´ëÅðÇǽŰæ
  • Lateral dorsal nerve of great toe
    °¡ÂʵîÂʾöÁö¹ß°¡¶ô½Å°æ
    [¿¾ ¿ë¾î] ¹«Áö¿ÜÃø¹èÃøÁö½Å°æ
  • Lateral dorsal cutaneous nerve
    °¡ÂʹߵîÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·¹èÇǽŰæ
  • Lateral plantar nerve
    °¡Âʹ߹ٴڽŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·Ã´½Å°æ
  • Lateral cutaneous nerve of forearm
    °¡ÂʾƷ¡ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÀü¿ÏÇǽŰæ
  • Lateral sural cutaneous nerve
    °¡ÂÊÀåµýÁöÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøºñº¹ÇǽŰæ
  • Lateral ampullar nerve
    °¡ÂÊÆØ´ë½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÃøÆØ´ëºÎ½Å°æ
  • Subcostal nerve
    °¥ºñ¹Ø½Å°æ
    [¿¾ ¿ë¾î] ´ÁÇϽŰæ
  • Intercostobrachial nerve
    °¥ºñ»çÀÌÀ§ÆÈ½Å°æ
    [¿¾ ¿ë¾î] ´Á°£»ó¿Ï½Å°æ
  • Abducent nerve (VI)
    °«µ¹¸²½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÀü½Å°æ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • longitudinal nerve trunk
    Á¾ÁֽŰ氣
  • Bachman intradermal test
    ¼±¸ðÃæÇdz»¹ÝÀÀ°Ë»ç
  • bentonite flocculation test
    º¥Å䳪ÀÌÆ®ÀÀÁý°Ë»ç
  • Casoni test
    Æ÷ÃæÇdz»¹ÝÀÀ°Ë»ç
  • circumoval precipitin test (COPT)
    Ãæ¶õÁÖÀ§Ä§°­°Ë»ç
  • intradermal test
    Çdz»¹ÝÀÀ°Ë»ç
  • Mazzotti test
    ¸¶Á¶Æ¼°Ë»ç
  • Montenegro test
    ¸óÅ״ϱ׷ΰ˻ç
  • Sabin-Feldman dye test
    (Åå¼ÒÆ÷ÀÚÃæ) »ö¼Ò¸é¿ª°Ë»ç
  • screening test
    ¼±º°°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • minimal medium
    ÃÖ¼Ò¹èÁö(õÌá³ÛÆò¢)
  • minimal stable length
    ÃÖ¼Ò¾ÈÁ¤(õÌá³äÌïÒ) ±æÀÌ
  • nerve gas
    ½Å°æ(ãêÌè)°³½º
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ(ãêÌèà÷íþì×í­)
  • purinergic nerve
    Ç»¸°¼º ½Å°æ(ãêÌè)
  • acrolein test
    ¾ÆÅ©·Ñ·¹ÀνÃÇè (ãËúÐ)
  • acute test
    ´Ü·® µ¶¼º½ÃÇè (Ó¤ÕáÔ¸àõãËúÐ)
  • adrenaline tolerance test
    ¾Æµå·¹³¯¸° ºÎÇϽÃÇè(ݶùÃãËúÐ)
  • albustix test
    ¾ËºÎ½ºÆ½½º½ÃÇè(ãËúÐ)
  • Ames test
    ¿¡ÀÓÁî °Ë»ç¹ý
  • antiglobulin consumption test
    Ç×(ù÷)±Û·ÎºÒ¸° ¼Ò¸ð½ÃÇè(á¼ÙÄãËúÐ)
  • antiglobulin test
    Ç×(ù÷)±Û·ÎºÒ¸° ½ÃÇè(ù÷ô÷ãËúÐ)
  • Aschheim-Zondek test
    ¾Æ»þÀÓ-Á¸µ¦ ½ÃÇè(ãËúÐ)
  • Ascoli test
    ¾Æ½ºÄݸ® ½ÃÇè(ãËúÐ)
  • Barfoed's test
    ¹Ù¸£ÆÐµå ½ÃÇè(ãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • pelvis perfusion test(Whitaker test)
    ½Å¿ì°ü·ù°Ë»ç
  • minimal
    ÃÖ¼ÒÀÇ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • minimal enhancement
    ¹Ì¹ÌÇÑÁ¶¿µÁõ°­, °æµµÀÇÁ¶¿µÁõ°­
  • arm to lung time test
    ÆÈÆó¼øÈ¯½Ã°£½ÃÇè
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • contraction test
    ¼öÃà°Ë»ç
  • double blind test
    ÀÌÁ߸Ͱ˹ý
  • dye dilution test
    »ö¼ÒÈñ¼®½ÃÇè
  • guaiac test
    °úÀ̾׽ÃÇè
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • laboratory test
    °Ë»ç
  • pivot shift test
    ÃßÃà º¯À§½ÃÇè
  • provocation test
    À¯¹ß½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NET nasoendotracheal tube; nerve excitability test; neuroectodermal tumor; neuroendocrine tumor; norepin...
MRD maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme...
PAT Pain Apperception Test; paroxysmal atrial tachycardia; patient; phenylaminotetrazole; physical abili...
EIM excitability-inducing material
MBD Marchiafava-Bignami disease; Mental Deterioration Battery; methylene blue dye; minimal brain damage;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NET Nerve Excitability Test
EMEM Eagle's Minimal Essential Medium
MAS Minimal Access Surgery
MAC Minimal Alveolar Concentration
MBC Minimal Bactericidal Concentration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • excitability
    ÈïºÐ¼º, ÇÇÀڱؼº
  • Eagle`s minimal essential medium
    ÀÌ±Û ¹èÁö
    ¼¼Æ÷ ¹è¾ç¾×ÀÇ ÀÏÁ¾. 3Á¾·ùÀÇ ¾Æ¹Ì³ë»ê°ú 8Á¾·ùÀÇ ºñŸ¹ÎÀ» ÇÔÀ¯Çϰí ÀÖÀ¸¸ç º¸Åë Ç÷û 5% ÀÌÇÏ¿¡¼­ À¯Áö ¹èÁö·Î¼­ »ç¿ëµÇ°í 10-20%ÀÇ Ç÷û ÷°¡·Î ¸¹Àº ¼¼Æ÷´Â ±ØÈ÷ ¾çÈ£ÇÑ ¹ßÀ°À» ³ªÅ¸³½´Ù.
  • minimal
    ÃÖ¼ÒÀÇ
    °¡Àå °¡´É¼ºÀÌ ÀûÀº.
  • minimal dose
    ÃÖ¼Ò·®
  • minimal enhancement
    ¹Ì¹ÌÇÑ Á¶¿µ Áõ°­, °æµµÀÇ Á¶¿µ Áõ°­
  • minimal identifiable odor
    ÃÖ¼Ò ºÐÇØ Ãë°¢
  • minimal requirement
    ÃÖ¼Ò ±Ô°Ý
  • minimal temperature
    ÃÖÀú ¿Âµµ
  • femoral nerve stretch test
    ´ëÅð ½Å°æ ½ÅÀü ½ÃÇè
  • accessory nerve
    ºÎ½Å°æ
    ¿îµ¿½Å°æÀ¸·Î, medulla oblongataÀÇ Àü¿ÜÃø¿¡¼­ ³ª¿À¸ç, cranial root¿Í s
  • accompanying vein of hypoglossal nerve
    Çô¹Ø½Å°æ µ¿¹Ý Á¤¸Æ
  • acoustic nerve
    û½Å°æ
    û·ÂÀ» ´ã´çÇÏ´Â ¿Í¿ì½Å°æ°ú ±ÕÇüÀ» ´ã´çÇÏ´Â ÀüÁ¤½Å°æÀ» °¡Áø °¨°¢ µÎ°³½Å°æ
  • afferent nerve
    ±¸½É¼º ½Å°æ, ±¸½É½Å°æ, ¼öÀԽŰæ
    1. ¸»ÃÊ¿¡¼­ ¾òÀº Á¤º¸¸¦ ½Å°æ°è¿¡ ÀüÇÏ´Â ½Å°æ. ´ëÇ¥ÀûÀ¸·Î ÇǺηκÎÅÍÀÇ ±¸½É½Å°æÀº ÃË, ¿Â, ³Ã, ¾ÐÅë µîÀÇ °¨°¢À» ÀüÇÑ´Ù. 2. °¨°¢ ¼ö¿ë±â·ÎºÎÅÍ ³ú, ô¼ö¸¦ ÇâÇØ ÀÓÆÞ½º¸¦ Àü´ÞÇÏ´Â ½Å°æ. 3. ¸»ÃÊ¿¡¼­ ÁßÃ߸¦ ÇâÇØ ÀÓÆÞ½º¸¦ º¸³»´Â ½Å°æ. ¿ø½É½Å°æ¿¡ ´ëÀÀÇÏ´Â °ÍÀ¸·Î °¨°¢½Å°æ°ú °°´Ù. °¨°¢¼¼Æ÷·ÎºÎÅÍ ³ª¿Í¼­ ô¼ö³ª ³ú·Î µé¾î°¡´Â ½Å°æÀε¥ °¨°¢¼¼Æ÷ÀÇ È°µ¿ »óŸ¦ ½Å°æÀÇ ÀÓÆÞ½º·Î½á Àü´ÞÇÑ´Ù.
  • afferent peripheral nerve
    ±¸½É¼º ¸»ÃʽŰæ
  • amyelinated nerve fiber
    ¹«¼ö ½Å°æ ¼¶À¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
supranormal excitability at the end of phase three of the cardiac action potential, the successful stimulation threshold falls below (i.e., less negative than) the level necessary to produce excitation during the rest of the phase of diastole, so that an ordinary subthreshold stimulus becomes effective.
Compare: supranormal conduction.
(05 Mar 2000)
excitability 1. The quality of being readily excited; proneness to be affected by exciting causes.
2. <physiology> The property manifested by living organisms, and the elements and tissues of which they are constituted, of responding to the action of stimulants; irritability; as, nervous excitability.
Origin: Cf. F. Excitabilite.
Source: Websters Dictionary
(01 Mar 1998)
minimal Smallest or least, the smallest possible.
Origin: L. Minimus = least
(18 Nov 1997)
minimal air The volume of gas that remains in the lungs and cannot be expelled after they have been removed from the body, or after the chest has been opened.
(05 Mar 2000)
minimal alveolar concentration The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics.
Synonym: minimal anaesthetic concentration.
(05 Mar 2000)
minimal amplitude nystagmus Nystagmus of so small an amplitude that it is not detected by the usual clinical tests.
Synonym: minimal amplitude nystagmus.
Origin: micro-+ G. Nystagmos, a nodding
(05 Mar 2000)
minimal anaesthetic concentration The end-alveolar concentration of an inhalation anaesthetic which prevents somatic response to a painful stimulus in 50% of individuals; an index of relative potency of inhalation anaesthetics.
Synonym: minimal anaesthetic concentration.
(05 Mar 2000)
minimal brain dysfunction An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal deviation melanoma <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis.
(05 Mar 2000)
minimal dose <pharmacology> The smallest amount of a drug or physical procedure that will produce a desired physiologic effect in an adult.
(05 Mar 2000)
minimal infecting dose <microbiology> The smallest quantity of infectious material regularly producing infection; usually expressed as I.D.50, the quantity causing infection in 50% of a suitable series of animals or cells (cell cultures).
(05 Mar 2000)
minimal inhibitory concentration <microbiology, pharmacology> The lowest concentration of antibiotic sufficient to inhibit bacterial growth when tested in vitro.
(05 Mar 2000)
minimal lethal dose <pharmacology> The minimal dose of a toxic substance or infectious agent that is lethal, as assayed in various experimental animals (e.g., the least amount of diphtheria toxin that, on an average, kills a 250-g guinea pig within 96 hours after subcutaneous inoculation).
When followed by a subscript (generally "MLD50"), denotes the minimal dose that is lethal to a certain percentage (e.g., 50%) of animals so assayed, LD05.
See: lethal dose.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excitability
    °ÝÇϱ⠽¬¿î ¼ºÁú;ÈïºÐ¼º
  • minimal
    ±Ø¼ÒÀÇ; ÃÖÀúÀÇ
  • minimal
    ÃÖ¼ÒÇâ(¼ö)ÀÇ;±Ø¼ÒÀÇ
  • minimal art
    ¹Ì´Ï¸Ö ¾ÆÆ®;ÃÖ¼ÒÇÑÀÇ Á¶Çü ¼ö´ÜÀ¸·Î Á¦ÀÛµÈ ±×¸²;Á¶°¢
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • minimal pair
    ÃÖ¼Ò ´ë¾î(bet¿Í bed ó·³ °°Àº À§Ä¡ÀÇ ÇÑ °¡Áö ¼Ò¸®¸¸ ´Ù¸¥ ÇÑ ½ÖÀÇ ³¹¸»)
  • nerve
    »·»·½º·¯¿ò
  • nerve-racking
    ½Å°æÀ» °Çµå¸®´Â
  • nerve-wracking
    ½Å°æÀ» °Çµå¸®´Â
  • cranial nerve
    ³ú½Å°æ
  • facial nerve
    ¾È¸é ½Å°æ
  • nerve
    ½Å°æ;Ä¡¼ö;(Åë¼ÓÀûÀ¸·Î)(ÀÌÀÇ)½Å°æ;±Ù¿ø;ÁßÃß;ÈûÁÙ;°Ç;¿ë±â;´ã·Â;±â·Â;Á¤½Å·Â;»·»·½º·¯¿ò;¹«·Ê;¹Î°¨ÇѰ÷(½Å°æ¿¡ °É¸®´Â)¹Ì¹¦ÇÑ Á¡;½Å°æÀÌ»ó(°ú¹Î);¾È´Þ;°Ì;¿ì¿ï;½Å°æ°ú¹ÎÁõ;È÷½ºÅ׸®;ÀÙ¸Æ;³¯°³¸Æ
  • nerve
    ÈûÀ» ÁÖ´Ù;¿ë±â¸¦ ºÏµ¸¿ì´Ù;°Ý·ÁÇÏ´Ù
  • nerve agent
    (±º¿ëÀÇ)½Å°æ°è¿¡ ÀÛ¿ëÇÏ´Â ¹°Áú;½Å°æ°¡½º(µî)
  • nerve block
    ½Å°æÂ÷´Ü(¹ý)(±¹ºÎ ¸¶ÃëÀÇ ÀÏÁ¾)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á